Essentialis, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2017-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
8
Active:0
Completed:5
Trial Phases
3 Phases
Phase 1:4
Phase 2:3
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (50.0%)Phase 2
3 (37.5%)Phase 3
1 (12.5%)A 5 Treatment Period Pharmacokinetic Study Evaluating Dose Proportionality and Food Effects of Diazoxide Choline Controlled-Release Tablet (DCCR)
Phase 2
- Conditions
- Prader-Willi Syndrome
- Interventions
- First Posted Date
- 2016-09-08
- Last Posted Date
- 2016-09-09
- Lead Sponsor
- Essentialis, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT02893618
Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome
- First Posted Date
- 2014-01-13
- Last Posted Date
- 2016-09-01
- Lead Sponsor
- Essentialis, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT02034071
- Locations
- 🇺🇸
University of California, Irvine, Orange, California, United States
Pharmacokinetic Study of Diazoxide Choline in Hypertriglyeridemic Subjects
Phase 1
Completed
- Conditions
- Hypertriglyceridmia
- Interventions
- First Posted Date
- 2010-09-30
- Last Posted Date
- 2014-01-10
- Lead Sponsor
- Essentialis, Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT01211860
- Locations
- 🇺🇸
Cetero, Fargo, North Dakota, United States
Efficacy Study of Diazoxide Choline to Treat Hypertriglyceridemia
Phase 2
Completed
- Conditions
- HypertriglyceridemiaDyslipidemia
- Interventions
- Drug: Placebo
- First Posted Date
- 2010-09-30
- Last Posted Date
- 2014-01-10
- Lead Sponsor
- Essentialis, Inc.
- Target Recruit Count
- 44
- Registration Number
- NCT01211847
Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High Triglycerides
Phase 3
Withdrawn
- Conditions
- Hypertriglyceridemia
- Interventions
- First Posted Date
- 2009-09-09
- Last Posted Date
- 2016-09-01
- Lead Sponsor
- Essentialis, Inc.
- Registration Number
- NCT00973271
- Prev
- 1
- 2
- Next
News
No news found